Analyst Ratings for Iterum Therapeutics (ITRM)
ITRM Rating Summary
ITRM Price Target Summary
- Highest: $2.50 (H.C. Wainwright)
- Lowest: $2.00 (RBC Capital)
- Average: $2.25
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$2.25 (+118.4%)
* Over Last 12-Mos
Rating Score: 5 / 10
Percentile Rank: 50%
Avg. $ Target:
$2.25 (+118.4%)
* Over Last 12-Mos
Rating Score: 5 / 10
Percentile Rank: 50%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/15/2021 | H.C. Wainwright | Ed Arce | Upgrade | Buy (Neutral) |
2.50 (N/A) |
1.55 (1.03) |
-33.55% | Details |
| 6/2/2020 | RBC Capital | Gregory Renza | Downgrade | Sector Perform (Outperform) |
2.00 (7.00) |
4.21 (1.03) |
-75.53% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
